The Effect of Motivational Interviewing-Based Education on Treatment Adherence and Self-Care Agency in COPD Patients

Not Applicable

Recruiting

• Conditions: Motivational Interviewing; COPD

• Registration Number: NCT06733662
• Lead Sponsor: Kahramanmaraş İstiklal University

Brief Summary

This randomized controlled trial will be conducted to evaluate the effect of education and motivational interviewing on treatment adherence and self-care power in COPD patients.

Hypotheses of the Study; H1: Education and motivational interviewing in COPD patients increase treatment adherence in patients.

H2: Education and motivational interviewing in COPD patients increase self-care power in patients.

There will be two groups in the study: control and intervention groups. Before the intervention, pre-test data will be collected in the control and intervention groups. After the intervention, post-test data will be collected in both groups in line with the data collection forms.

Detailed Description

In line with the randomization list, patients will be assigned to the intervention and control groups in line with the inclusion criteria. Pre-test data will be collected face-to-face in the intervention group in accordance with the data collection forms. After collecting the pre-test data, the patient will be allowed to rest for about 10 minutes, and then COPD training will be given to the patient in a single session lasting about 45-50 minutes in line with the training booklet and by evaluating the pre-test data. The education booklet will be given to the patient. On the 3rd day, the first session of motivational interview will be held. On the 5th day and 7th day and 15th day, motivational interview sessions will continue with the patients. During the motivational interview, patients will be supported in line with the training booklet. On the 30th day, the patient will be interviewed face-to-face and post-test data will be collected.

Patients in the control group will be interviewed and no intervention will be made after the pre-tests are applied. Patients in the control group will continue their routine controls. In the final test (1st month), an appointment date will be set with the patient and the final test data will be collected face-to-face.

Study Timeline

• Study Start: 2024-08-15
• Status Verified: 2024-12
• Study First Submitted: 2024-12-10
• Study First Submitted QC: 2024-12-10
• Last Update Submitted: 2024-12-10
• Study First Posted: 2024-12-13
• Last Update Posted: 2024-12-13
• Primary Completion: 2025-01-10
• Study Completion: 2025-02-15

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Confirmed diagnosis of COPD for at least 6 months
• Admitted to the chest clinic
• No communication problems
• Patients who volunteered to participate in the study.

Exclusion Criteria

• In the period of exacerbation
• Uncooperative due to dyspnea
• With a malignant disease
• Patients with a confirmed diagnosis of psychiatric illness

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Morisky 8-item Medication Adherence Scale	30 days	It is a scale that assesses self-reported medication use behaviors of the patient. It consists of eight questions. A validation study in Turkish was conducted by Oğuzülgen et al. in 2014. While the first seven questions are answered as "yes/no", the eighth question is answered on a five-point Likert scale as "never/rarely", "sometimes", "sometimes", "usually" and "always". Morisky 8-item medication adherence scale is calculated between 0-8 points.
Self-care Agency Scale	30 days	The scale was developed by Kearney and Fleischer and its validity and reliability study in Turkey was conducted by Nahcivan in 1993. In Nahcivan's study, the Cronbach's alpha coefficient of the scale was found to be 0.92. This scale, in which individuals self-assess their ability or power to perform self-care actions, consists of 35 items. The maximum score to be obtained from the scale is 140. As the score obtained from the scale increases, the self-care power of the patients also increases.

Trial Locations

Locations (1)

Kahramanmaraş Istiklal Universty; 🇹🇷 Kahramanmaraş, Turkey